- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00004838
Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children
OBJECTIVES:
Compare growth of lead-poisoned children receiving succimer (dimercaptosuccinic acid; DMSA) plus standard treatment to those receiving standard treatment only.
Study Overview
Detailed Description
PROTOCOL OUTLINE: This is randomized study. Patients are randomized to receive succimer in addition to standard treatment (arm I) or standard treatment only (arm II).
Succimer is administered orally 3 times a day for 7 days, then twice daily for 19 days. Patients may receive up to 3 courses.
Standard treatment consists of a medical history and physical examination, environmental assessment with modification to reduce lead exposure, dietary modifications to decrease lead absorption, the use of a daily multivitamin and mineral supplement with iron, developmental screening and intervention, and frequent follow up of lead levels.
If blood lead level rises above 45 mcg/dL, patient receives succimer regardless of treatment arm originally assigned.
Patients are followed every 3-4 weeks for 2 months, then every 3 months for 6 months, and then every 6 months thereafter.
Study Type
Enrollment
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics-- Asymptomatic children with confirmed venous blood lead of at least 20 mcg/dL and less than 45 mcg/dL Children with blood lead of 45 mcg/dL or greater are not randomized in this study since they probably will receive succimer regardless of being enrolled in this study --Patient Characteristics-- Other: No contraindications to the use of succimer (i.e., allergy or a lack of lead safe environment in which to live during chelation)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Marcel J. Casavant, Nationwide Children's Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 199/13576
- CHRF-96-HS-066
- CH-OHIO-5F32ES05651
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lead Poisoning
-
National Institute of Environmental Health Sciences...Completed
-
University of JohannesburgMedical Research Council, South AfricaEnrolling by invitationLead Poisoning | Lead Poison ChildrenSouth Africa
-
National Institute of Environmental Health Sciences...Health Canada; Danish Institute for Public Health; Indian and Northern Affairs...Completed
-
Arslan SaleemBaqai Medical UniversityActive, not recruiting
-
National Institute of Environmental Health Sciences...Completed
-
Federal University of São PauloCompleted
-
China Medical University, ChinaCompleted
-
National Institute of Environmental Health Sciences...CompletedLead PoisoningUnited States
-
National Institute of Environmental Health Sciences...CompletedLead Poisoning
-
Boston UniversityOhio State University; Centers for Disease Control and Prevention; US Department...Recruiting
Clinical Trials on succimer
-
National Institute of Environmental Health Sciences...Completed
-
China Medical University, ChinaCompleted
-
Southwest College of Naturopathic MedicineCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome and other conditionsUnited States